We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/9/2016 10:35 | Time they started increasing the dividends imo. | gbh2 | |
16/9/2016 09:41 | Apex acquisition (Australia/NZ)and base for Asian expansion.looks very sound.The total consideration for the Acquisition, which is expected is to complete on 14 October 2016, is AUS$55.0 million (£31.3 million). This will be funded from the Group's own cash and debt resources. The acquisition is expected to be earnings enhancing in the first 12 months. | steeplejack | |
05/9/2016 19:46 | IC update: After a strong trading update last month, full-year results from veterinary group Dechra (DPH) are unsurprising, but no less impressive. Revenues and adjusted operating profit are both up by over a fifth and three acquisitions completed in the period have enhanced the outlook. Shares are up 3 per cent this morning and we continue to see an upside. Buy. | philanderer | |
05/9/2016 12:37 | 'Dechra finds winning growth formula' | philanderer | |
05/9/2016 11:08 | Good figures,9% uplift in dividend for year.Steady as she goes. | steeplejack | |
16/7/2016 10:37 | APAD we all make mistakes i got caught holding a couple of challenger banks PAG and OSB after the Brexit vote. I didn't expect anything like the falls they had, although i have added to my holdings. I guess the secret is to have more big winners and small losers. Fortunately I manage to do that more often than not. wc | woodcutter | |
16/7/2016 10:34 | It's pulled back from resistance and Fridays gap down at the open coupled with an end of day doji candle pattern doesn't inspire confidence that the share price will rise. Indeed mondays move will signal the immediate future direction in my view and i feel it's likely to fall back to around support at 1100p. (There's weaker support around 1150p) MCX the mid cap index is also indicating a pull back candle pattern after Fridays hanging man. The fundamentals aren't favourable with £gbp bouncing and no change in interest rates. A breakout above resistance into open water would tempt me back in as would a pull back to resistance around 1100p but for now it's in no mans land. With a potential mild recession possible it's important to consider the currency movements and also the operational gearing of every business you're invested in at present. With DPH admin cost around 40% of sales that's not too bad although I'd prefer it less than 30% if possible. woody | woodcutter | |
14/7/2016 10:18 | Numis recommends "add" and sets target at 1310p | steeplejack | |
12/7/2016 17:36 | You're very kind Woody, but I make as many mistakes as anyone else. It's taken me a long time to realise that, for me, it is sensible to exit in stages - but to keep a residual holding so that a good company is still on the radar. Otherwise I flibbertigibbet all over the bloody place. I thought that entering in stages was now in my dna, but I bought more GDWN than I intended (fat finger) and didn't have the sense to correct it! Still sitting on a 40% loss, even though it's a great company. apad | apad | |
12/7/2016 13:46 | Consensus eps for the year to end June 2017 is for eps of around 51p,putting the stock on a prospective PE of 24,yielding 1.7% .With 20% growth anticipated in the 2016/17 year,the PEG ratio is an undemanding 1.2 Difficult to see the stock pushing ahead aggressively from here but with a full year of the US acquisitions to be accounted for, any sterling weakness could benefit the share price.This is a relatively illiquid,thin share market .The shares have a history of retrenching after a share price run but if fresh institutional buyers emerge,which is quite possible in these nervous markets,the stock could yet surprise on the upside. | steeplejack | |
12/7/2016 10:59 | APAD your a canny investor I'm sure you've more than made up for it elsewhere! woody | woodcutter | |
12/7/2016 09:18 | Seconded, but I didn't have your timing on buying back in, Woody. apad | apad | |
12/7/2016 09:02 | I'd bought back in on the recent falls but have sold out again this morning. The TS was decent but focused on revenue growth with little mention of profits. The revenue was only just ahead of forecast from digital look so i figure profits in line. The rating is racy and it is now up against historic chart resistance with -ve divergence on the RSI so i've taken profits. it's a sound business so will buy back in on any weakness woody | woodcutter | |
12/7/2016 08:57 | Heady rating but wearable.Looks like a good sound investment. | steeplejack | |
23/2/2016 23:10 | Says it all.Humans might be indifferent to the plight of their fellow man but nothing's too good for ol' Fido or pets in general! | steeplejack | |
22/2/2016 08:33 | That will do! | phillis | |
18/2/2016 11:29 | now looking forward to Mondays results RNS | phillis |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions